We serve 4-(Boc-amino)-1-butanol CAS:75178-87-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:4-(Boc-amino)-1-butanol
CAS.NO:75178-87-9
Molecular Formula: C9H19NO3
Molecular Weight:189.25200
Synonyms:
Tert-Butyl N-(4-Hydroxybutyl)Carbamate
tert-butyl (4-hydroxybutyl)carbamate
Physical and Chemical Properties:
Density: 1.02 g / mL at 20ºC (lit.)
Boiling point: 302.7ºC at 760 mmHg
Flash point: 29ºC
Refractive index: n20 / D 1.456
Specification:
Appearance:White powder
Purity:≥99%
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store at 2-8ºC.Keep the container tightly closed, put it in a tight dispenser, and store in a cool, dry place.
Application:An intermediate for the synthesis of polymers used for in vivo delivery polyconjugate systems.
Contact us for information like 4-(Boc-amino)-1-butanol chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,tert-butyl (4-hydroxybutyl)carbamate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-(Boc-amino)-1-butanol Use and application,4-(Boc-amino)-1-butanol technical grade,usp/ep/jp grade.
Related News: The Company has established a leadership position in the clinical development and manufacture of universal, off-the-shelf cell products using its proprietary induced pluripotent stem cell (iPSC) product platform.N,N'-Bis(acetoacetyl)-o-toluidine manufacturer But the ban from Italy remains, Joseph Wu, Taiwan’s foreign minister, said on Sunday.5-(2,4,6-trimethylphenyl)cyclohexane-1,3-dione supplier But the ban from Italy remains, Joseph Wu, Taiwan’s foreign minister, said on Sunday.1-Bromo-2,6-difluorobenzene vendor You will find the name and amount of the active ingredient contained in the medicine on the package of OTC (over-the-counter) drugs.Onconova Therapeutics, Inc. is a Phase 3-stage biopharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, with an initial focus on Myelodysplastic Syndromes (MDS).
